IL-33 activates tumor stroma to promote intestinal polyposis.
about
Cytokine-Induced Modulation of Colorectal CancerDamage-associated molecular patterns in cancer: a double-edged swordAn antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33.Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironmentIL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesisThe Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.A novel isoform of IL-33 revealed by screening for transposable element promoted genes in human colorectal cancerInterleukin 33 is a guardian of barriers and a local alarmin.IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer.IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.Tumour-associated changes in intestinal epithelial cells cause local accumulation of KLRG1+ GATA3+ regulatory T cells in mice.Interleukin-33 in health and disease.Determinants of metastatic competency in colorectal cancer.The Heterocellular Emergence of Colorectal CancerIL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice.Interleukin-33 promotes inflammation-induced lymphangiogenesis via ST2/TRAF6-mediated Akt/eNOS/NO signalling pathway.High-Fat Diet-Induced Complement Activation Mediates Intestinal Inflammation and Neoplasia, Independent of Obesity.Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer.Alarmins and immunity.A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach.Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.Decreased IL-33 Production Contributes to Trophoblast Cell Dysfunction in Pregnancies with Preeclampsia.Cytokine Tuning of Intestinal Epithelial Function.Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.IL-33/ST2 Axis in Organ FibrosisThe Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang CytokineThe Role of IL-33/ST2 Pathway in Tumorigenesis
P2860
Q26752374-2080906B-A048-48A2-B736-0EB349D9BABDQ28067434-31702CD4-E9A5-4278-A209-3FB0E52E4618Q36473012-2C1F5DAF-1FED-42FB-8959-AC4C925FCA1FQ37251140-9EBBF2DC-5214-4C7F-9C73-422E0D101CB0Q37439634-4216ACC4-2F6E-466B-9B9E-3E60C7A33D98Q37452192-A174075A-8792-4FFE-91D7-4ADFDD060089Q37571181-9C3EBD0B-DC9E-4309-A0AE-6AE33E3783FBQ38675614-CBF50153-ED8C-4D27-8FBC-44903ED04954Q38702558-A971AA54-EAAC-4E52-8026-C3F4FCE33CF1Q38722744-566AAB93-4F41-4BE9-8FB0-3E028F2568C0Q38775054-3DFDC14C-ED1B-45F1-A668-F164F9D747DEQ38783993-ACCDC33C-3F4A-4AAF-AA03-22D810B85EC2Q38823204-6309183E-CAE4-455D-A841-08691A47348AQ38957840-3E305929-A3BA-47D6-B6D1-61D8BEF5699FQ39085740-69654F08-35FF-4634-B1EF-41C7057F6E7CQ39152114-AB1194D0-0156-4845-9930-265B1087FECCQ40312760-B401F8A8-D70C-4757-A923-82AF3AD6D720Q41019883-4D49DDBE-F683-4D5A-85F4-6B3240B508F9Q41636753-12026BCE-448D-4BE1-A132-8D3EB88C4A33Q41653522-8456EC8A-BAB4-43A7-811C-0A12612FD4E7Q47285890-B22ACA33-EE63-467E-B221-678512C57FF5Q47681122-3D4FE7BF-37F9-41D9-BE21-0B9B7900F036Q47718005-2FF6BDBB-23F2-4803-BB38-431439DD0BEBQ48193695-0DD07039-8B4B-47C0-8B6F-F49A4BD9E6BDQ50455880-8854F137-1692-40E9-83AC-53E33997DE85Q52641579-E7281E2C-2E70-4798-B88C-77CB8077D4B7Q54996569-8E5CA6F3-17DE-4BE2-BEFB-21A426FF6F02Q55167657-56F136A2-33F8-4B09-9FB7-061C2A6BD29DQ55373264-D546EAFE-EE4C-4CFC-A474-20EAC8E787A6Q58566658-BCC6DB23-1D81-4559-8190-74223CFFA323Q58707724-56F95875-2993-4A88-AD8F-B1C50448DE01Q58756972-50F7171C-15EC-46E8-87C7-0FDACD7F2324
P2860
IL-33 activates tumor stroma to promote intestinal polyposis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IL-33 activates tumor stroma to promote intestinal polyposis.
@ast
IL-33 activates tumor stroma to promote intestinal polyposis.
@en
type
label
IL-33 activates tumor stroma to promote intestinal polyposis.
@ast
IL-33 activates tumor stroma to promote intestinal polyposis.
@en
prefLabel
IL-33 activates tumor stroma to promote intestinal polyposis.
@ast
IL-33 activates tumor stroma to promote intestinal polyposis.
@en
P2093
P2860
P50
P356
P1476
IL-33 activates tumor stroma to promote intestinal polyposis
@en
P2093
Carlo De Salvo
Denise G Lanza
Jason D Heaney
Joseph H Nadeau
Nathan A Berger
Rebecca L Maywald
Sanford D Markowitz
Stephanie K Doerner
Susan M Benton
Theresa T Pizarro
P2860
P304
P356
10.1073/PNAS.1422445112
P407
P577
2015-04-27T00:00:00Z